Bright Green

BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING

Retrieved on: 
Tuesday, March 12, 2024
DEA, Research, Carbon, Ground substance, Optimism, Bright Green, Pharmaceutical industry

The proposed expansion will add 7 million square feet of manufacturing and production capabilities.

Key Points: 
  • The proposed expansion will add 7 million square feet of manufacturing and production capabilities.
  • The Dalsem Agreement provides that Dalsem will construct the additional facility to its specifications and build them in a modular fashion.
  • Additionally, the Company has entered into a credit agreement with a lender for a $60 million senior debt financing to fund the expansion construction project (the “Credit Agreement”).
  • This expansion is a direct result of Bright Green obtaining the regulatory approvals for the production of Schedule I and II controlled substances from the DEA and the State of New Mexico Board of Pharmacy.

Bright Green Corporation announces the agreement to acquire platform technologies and associated intellectual property from C2 Wellness Corp.

Retrieved on: 
Thursday, January 25, 2024
Novel, University, Research, Associate, Health, Partnership, Discovery, API, Innovation, Georgetown University, Senior advisor, Acquisition, Bright Green, Polymer, Safety, Intellectual property, Doctor of Philosophy, THC, LLM, Fine chemical

Grants, New Mexico, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) today announced the agreement to purchase assets from C2 Wellness Corporation.

Key Points: 
  • Grants, New Mexico, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) today announced the agreement to purchase assets from C2 Wellness Corporation.
  • (“C2”), a Wyoming registered company with an address at 30 N Gould St, Ste R, Sheridan, WY, that owns certain platform technologies and associated intellectual property invented and developed by the scientific team of C2.
  • The purchase is for 5 million shares of common stock of Bright Green Corporation payable to all shareholders of C2.
  • This groundbreaking collaboration involves the acquisition of innovative CBD and THC-based molecules from C2 Wellness Corp by Bright Green Corporation,” said Lynn Stockwell.

Bright Green Announces Third Quarter 2023 Financial Update and Milestone Progress

Retrieved on: 
Wednesday, November 22, 2023
Marketing, Partnership, Cannabis, Bright Green, Government, Research, USCIS, EB-5, Green, Ground substance, Drug

GRANTS, N.M., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications, and affiliated export, reported financial results for the quarter ended September 30, 2023.

Key Points: 
  • Bright Green has achieved several key milestones throughout the Quarter advancing progress against its strategic plan.
  • GRANTS, N.M., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications, and affiliated export, reported financial results for the quarter ended September 30, 2023.
  • To date, Bright Green has sold 44,010 shares of common stock at $39.99 per share, receiving proceeds of approximately $1.76 million.
  • Additional information is included in the Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2023, which can be accessed at: https://investors.brightgreen.us/news-events/news-releases

Bright Green Corporation announces exclusive partnership with Asia Capital Pioneers Group to present new EB-5 offering

Retrieved on: 
Thursday, November 16, 2023
Sale, United States Congress, Food, ACPG, Investment, Ground substance, Ghana Immigration Service, API, Second Continental Congress, Partnership, Rule, DEA, Bright Green, Active ingredient, Congress, Food and Drug Administration, EB-5, Optimism, Pharmaceutical industry

GRANT, N.M., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (BGXX) (“BGXX”, “Bright Green” or the “Company”) today announced the Company’s new alliance with Asia Capital Pioneers Group Inc. (“ACPG”), an Asia-based investment firm with global investments within high growth industries.

Key Points: 
  • GRANT, N.M., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (BGXX) (“BGXX”, “Bright Green” or the “Company”) today announced the Company’s new alliance with Asia Capital Pioneers Group Inc. (“ACPG”), an Asia-based investment firm with global investments within high growth industries.
  • The partnership comes in conjunction with Bright Green’s new EB-5 offering of 100,000 shares at a price of $8.80 per share and an initial 3-year lockup.
  • The Company has since established Regional Center Bright Green to manage the processing of the EB-5 investments.
  • Bright Green’s CEO, Groovy Singh, spoke openly about his optimism for the opportunity the partnership will provide.

U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer

Retrieved on: 
Tuesday, October 3, 2023
International, McAuley, Stanford University, CPG, Medicine, EB-5, Research, Teva Active Pharmaceutical Ingredients, Certification, DEA, OPM, Commerce, Harvard Business School, Office of the Immigration Services Commissioner, Cannabis, Growth, Billabong, Real estate, Pharmaceutical industry, Management, Bright Green, Reebok, The Walt Disney Company, Agtech

Mr. Singh addressed his appointment on Monday with enthusiasm, stating, “I think Bright Green is positioned with an opportunity to not only be the premier cultivator, manufacturer, and supplier of a new, groundbreaking class of Active Pharmaceuticals Ingredients, but also to form a trusted network of domestic and international partners that can facilitate the expansion of this impactful approach to medicine and therapies. This is the vision that is shared across the Founders and Board Members of Bright Green -- to have everything under one roof and “Made in the USA” from start to finish.” Singh continued, “I am eager to leverage the monumental achievements that Bright Green’s leadership has already solidified, including the EB-5 program and our existing international exposure—an element I am particularly looking forward to building on.”

Key Points: 
  • GRANTS, N.M., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), announced today their appointment of Groovy Singh, a renowned leader and strategist in the cannabis and wellness industries, as Chief Executive Officer.
  • Singh will replace current CEO Seamus McAuley, who is stepping back from the position to address recently developed health-related concerns.
  • McAuley will assume an advisory role to Mr. Singh during the transition to continue facilitating the company’s success while remaining focused on his recovery.
  • We offer him nothing but our support moving forward,” Terry Rafih, Executive Chairman of the Board of Directors for Bright Green said Monday.

Bright Green Announces Second Quarter 2023 Financial Update and Milestone Progress

Retrieved on: 
Thursday, August 17, 2023
Common stock, Bright Green, Marketing, Special-purpose acquisition company, Research, USCIS, EB-5, Sale, Government, Green, Acquisition, DEA, Cannabis, Ghana Immigration Service, Nursing, Drug, Renewable energy, Security (finance), Grant

GRANTS, N.M., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications, and affiliated export, reported financial results for the quarter ended June 30, 2023.

Key Points: 
  • Bright Green has achieved several key milestones throughout the Quarter significantly advancing progress against its strategic plan, including a historic DEA Federal Registration and License Approval.
  • GRANTS, N.M., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications, and affiliated export, reported financial results for the quarter ended June 30, 2023.
  • To date, Bright Green has sold 44,010 shares of common stock at $39.99 per share, receiving proceeds of $1.76 million.
  • Additional information is included in the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2023, which can be accessed at: https://investors.brightgreen.us/news-events/news-releases

Bright Green Operational Update

Retrieved on: 
Thursday, August 10, 2023
Partnership, Bright Green, Grant, Genetics, Pharmacovigilance, EB-5 visa, Cannabinoid, Innovation, Research, EB-5, Grants, New Mexico, Government, Plant, LED, Documentation, DEA, CGMP, Cannabis, Climate, FDA, SVP, Controlled-environment agriculture, Safety, Automation, Disease, Fine chemical, Bright

GRANTS, N.M., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of the few companies selected by the U.S. government to grow, manufacture, and sell, legally under both federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced that specific plants have now been selected for the test crops at its Grants New Mexico facility, and the company gives its operational updates.

Key Points: 
  • GRANTS, N.M., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of the few companies selected by the U.S. government to grow, manufacture, and sell, legally under both federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced that specific plants have now been selected for the test crops at its Grants New Mexico facility, and the company gives its operational updates.
  • Bright Green was instrumental in shaping this new program and is authorized to utilize the company’s Grants, New Mexico facility to produce high-quality cannabis intended for pharmaceutical and other product applications.
  • As a DEA-approved project, the largest of its kind, Bright Green has partnered with Controlled Environment Agriculture Design ( CEAd ), team of project managers, engineers, designers, and industry professionals who specialize in technical consulting services for the controlled environment agriculture industry.
  • We currently have cultivars highly suitable to Bright Green’s pharmaceutical platform and look forward to developing custom breeds, with a focus on increasing the availability of minor cannabinoids that BG off-takers will require.”

Bright Green announces plans to launch a program to support as many as 170 universities for cannabis research in the United States as well as an extension of the Company’s EB-5 initiative to enable foreign students attending universities in the United Sta

Retrieved on: 
Monday, July 17, 2023
Learning, Green, International, Bright Green, Citizenship of the United States, University, Research, Medicine, USCIS, EB-5, Bright, Government, Organization, Student, DEA, System, Green card, Engineering, Cannabis, Knowledge, Pharmaceutical industry, Nursing

GRANTS, N.M., July 17, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or “the Company”), one of the few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export, today announced that it is launching a university based EB-5 initiative to provide foreign students attending universities in the United States the opportunity to purchase an EB-5 visa through Bright Green. Given that the U.S. has the largest number of top universities in the world, it is one of the most preferred destinations for foreign students to pursue their studies. Becoming US Green Card holders not only allows students to live and work permanently in the United States both during and after graduation, but can provide real, tangible benefits not available to international students such as reduced tuition fees.

Key Points: 
  • The extension of the Bright Green’s EB-5 offering to foreign students studying in the U.S. will offer the benefits of U.S. citizenship to the students and provide capital to the Company.
  • Given that the U.S. has the largest number of top universities in the world, it is one of the most preferred destinations for foreign students to pursue their studies.
  • First, raising capital to execute on our plans for the business, a primary focus for the Company moving forward.
  • A further challenge is posed during summers when the majority of other US students are able to secure paid internships.

Bragar Eagel & Squire, P.C. Is Investigating RH, Hayward Holdings, Bright Green, and Veradigm and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, June 20, 2023
P.C, Green market, Bright Green, MDRX, Bank statement, Green, Annual report, News, NYSE, Bankruptcy, Cryptocurrency, Audit, RH

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Additional information about each case can be found at the link provided.
  • On February 6, 2023, RH announced that it expects 2022 revenue growth at the lower end of the prior range of (3.5%) to (4.5%).
  • On this news, Bright Green’s stock price fell $0.56 per share, or 15.56%, to close at $3.04 per share on June 3, 2022.

Bright Green Announces Closing of $3.5 Million Private Placement

Retrieved on: 
Wednesday, May 24, 2023
Benchmark, Exercise, Regulation D, Research, The Act, Government, Sale, Cannabis, Security (finance), EF Hutton, Bright Green

GRANTS, N.M., May 24, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications, and affiliated export, today announced the closing of its previously announced private placement of common stock and warrants.

Key Points: 
  • GRANTS, N.M., May 24, 2023 (GLOBE NEWSWIRE) -- Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications, and affiliated export, today announced the closing of its previously announced private placement of common stock and warrants.
  • The gross proceeds to the Company from the private placement are expected to be approximately $3.5 million before deducting the placement agent's fees and other estimated offering expenses.
  • EF Hutton, division of Benchmark Investments, LLC, acted as the exclusive placement agent for the offering.
  • Bridgeway Capital Partners served as financial advisor to Bright Green on the offering.